Hesai Group (HSAI)
NASDAQ: HSAI · Real-Time Price · USD
18.73
-0.27 (-1.42%)
Aug 1, 2025, 4:00 PM - Market closed
Singular Genomics Systems Stock Forecast
Stock Price Forecast
The 2 analysts that cover Singular Genomics Systems stock have a consensus rating of "Strong Buy" and an average price target of $27.65, which forecasts a 47.62% increase in the stock price over the next year. The lowest target is $26 and the highest is $29.3.
Price Target: $27.65 (+47.62%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Singular Genomics Systems stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 1 |
Hold | 1 | 1 | 1 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 1 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Morgan Stanley | Morgan Stanley | Hold → Buy Upgrades $23 → $26 | Hold → Buy | Upgrades | $23 → $26 | +38.81% | Jul 28, 2025 |
Jefferies | Jefferies | Strong Buy Initiates $29 | Strong Buy | Initiates | $29 | +56.43% | Jun 9, 2025 |
Citigroup | Citigroup | Strong Buy Initiates $13 | Strong Buy | Initiates | $13 | -31.13% | Sep 26, 2023 |
Goldman Sachs | Goldman Sachs | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 18, 2023 |
Financial Forecast
Revenue This Year
3.36B
from 2.08B
Increased by 61.71%
Revenue Next Year
4.83B
from 3.36B
Increased by 43.70%
EPS This Year
2.11
from -0.79
EPS Next Year
4.54
from 2.11
Increased by 115.76%
Financial currency is CNY. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 4.1B | 7.7B | 7.6B | ||
Avg | 3.4B | 4.8B | 6.2B | ||
Low | 3.0B | 4.0B | 5.0B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 99.6% | 129.2% | 57.0% | ||
Avg | 61.7% | 43.7% | 29.0% | ||
Low | 43.6% | 17.9% | 4.6% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 3.09 | 8.00 | 11.36 | ||
Avg | 2.11 | 4.54 | 7.20 | ||
Low | 1.39 | 2.37 | 3.74 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | 280.0% | 150.0% | ||
Avg | - | 115.8% | 58.5% | ||
Low | - | 12.5% | -17.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.